Publication | Closed Access
A phase III randomised trial of LV5FU2 + irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802)
200
Citations
14
References
2009
Year
OncologyGastrointestinal OncologyMedicinePhase IiiColorectal CancerPharmacotherapyCancer TreatmentFnclcc Accord02/ffcd9802PharmacologyRadiation OncologyCancer Research
| Year | Citations | |
|---|---|---|
Page 1
Page 1